speb/financial-data huggingface dataset:
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 873990000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 181720000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 181720000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 100340961.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 2.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 201090000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — EBIT: 312880000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — EBITDA: 494600000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 1098580000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 48530000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 48530000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Net Income: 201090000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 201090000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 201090000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 201090000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 201090000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 201090000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -48530000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -48530000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 494600000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 201090000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Operating Income: 259220000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 1972570000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 53660000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 328420000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 264350000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 873990000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 181720000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 63260000.00
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.24
NEPHROPLUS.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 1713350000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — +Operating Expense: 2971210000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 913640000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — +Total Revenue: 7483440000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 2191930000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 1128820000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1128820000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 2664170000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 2664170000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -2758720000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -2758720000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 6065760000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 6065760000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -290040000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -290040000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Amortization: 28100000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 28100000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 3510000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 3510000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 100340961.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 100340961.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Basic EPS: 6.69
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 2.48
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 611510000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 1587490000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 1587490000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -1007970000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 319750000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 319750000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 17650000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 17650000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 1258170000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1258170000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1891620000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1891620000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 237750000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 237750000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 1020420000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 1020420000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 670000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -27880000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -158400000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Change In Payable: 398710000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -667310000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -441730000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 646450000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Common Stock: 17650000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 17650000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 5841130000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 5841130000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 979650000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 104340000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 104340000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 3522390000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 959040000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Current Assets: 5453570000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 5453570000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 70990000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 70990000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Current Debt: 1298040000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 1298040000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 1369030000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1369030000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 2838950000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 2838950000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 15460000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Depreciation: 696590000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 724690000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 724690000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 193750000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 696590000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 193750000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 100340961.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 100340961.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Diluted EPS: 6.69
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 2.48
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 670960000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 248680000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — EBIT: 1063040000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — EBIT: 360390000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — EBITDA: 1787730000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — EBITDA: 554140000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 210000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — End Cash Position: 1258170000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 543710000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 345500000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -7550000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Gain Loss On Sale Of PPE: 0.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 172600000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Goodwill: 555100000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 555100000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 722550000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 722550000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 2954210000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 2954210000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 6103510000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 6103510000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Gross Profit: 3961050000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 1232890000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Impairment Of Capital Assets: 0.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Interest Expense: 188670000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 61160000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 188670000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 61160000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Interest Income: 119550000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 119550000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -188100000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 130860000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Inventory: 266230000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 266230000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 8099150000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 8099150000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -1250730000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 3510000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 3510000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Issuance Of Capital Stock: 979650000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 81050000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 248760000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 248760000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 959980000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 959980000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1208740000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1208740000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 0.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -252260000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 48200000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 4411680000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 4411680000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Net Business Purchase And Sale: -125410000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Net Common Stock Issuance: 979650000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Net Debt: 999850000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 999850000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: 0.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Net Income: 670960000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Net Income: 248680000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 670960000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 248680000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 670960000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 248680000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 670960000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 248680000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 670960000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 248680000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 874370000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 670960000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 248680000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Net Intangibles Purchase And Sale: -10220000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Net Interest Income: -88790000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -61160000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 47270000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: -171210000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: -252260000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -88790000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -61160000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: 20000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -295480000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Net PPE: 3344790000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 3344790000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -997750000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: 81050000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 5118580000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 5118580000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 205680000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 205680000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 20380000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 20380000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 48200000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 48200000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 58770000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 58770000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 1818240000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 554140000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Normalized Income: 694372273.52
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 248680000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 1353470000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Operating Income: 989840000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Operating Income: 319250000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Operating Revenue: 7483440000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 2191930000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 100340717.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 100340717.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 13310000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 13310000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 158830000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 158830000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 162260000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 162260000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Other Intangible Assets: 167450000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Other Intangible Assets: 167450000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 33450000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 84060000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 13930000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 41140000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 831260000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 377820000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Other Payable: 83990000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 83990000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Other Properties: 3240450000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 633450000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 633450000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Payables: 1266260000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Payables: 1266260000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 15460000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 15460000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 156500000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 156500000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Pretax Income: 874370000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 299230000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 77950000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: -125410000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Purchase Of Intangibles: -10220000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -1513650000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -997750000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 3522390000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 959040000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 724690000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 193750000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 37750000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 37750000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -252260000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 461740000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 461740000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: -306100000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -306100000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 1560920000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 0.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 52970000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 225570000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Share Issued: 100340717.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 100340717.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 81050000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Special Income Charges: -38060000.00
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 63800000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 5841130000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 5841130000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 5118580000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 5118580000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -7097726.48
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Tax Provision: 203410000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 50550000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.23
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.17
NEPHROPLUS.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -9570000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Total Assets: 9964600000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 9964600000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 6801110000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 6801110000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Total Debt: 2577770000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 2577770000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 5841130000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 5841130000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Total Expenses: 6493600000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 1872680000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 4123470000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 4123470000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 4511030000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 4511030000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1284520000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1284520000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 19670000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 53450000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 53450000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -30510000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -30510000.00
NEPHROPLUS.NS balance_sheet (annual, 2025-03-31) — Working Capital: 2614620000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 2614620000.00
NEPHROPLUS.NS income_statement (annual, 2025-03-31) — Write Off: 38060000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1289600000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 3286700000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -3084650000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 7044140000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -361080000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 770000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 1921790000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 544340000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 36180000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 829650000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 2088660000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Cash Equivalents: 102180000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Cash Financial: 727470000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 36180000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 7170000000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 202270000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 6514790000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 105700000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 1621980000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1727680000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 3672400000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 763570000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 1013410000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 3647780000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 7022530000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 340370000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 9240390000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 770000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 438640000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 448410000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 887050000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 4898470000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 1240740000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 3937880000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 6156590000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 341630000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 146430000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 53670000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 57670000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 100340717.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 44670000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 336730000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 231070000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 249840000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Other Payable: 158460000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 1259010000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Payables: 1547500000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 19560000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 444860000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 309530000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -153300000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 100340717.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 7170000000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 6156590000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 11936750000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 7618410000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 2614730000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 7170000000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 4766750000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 5421960000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1094350000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 99440000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 2842390000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1115330000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 2597290000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 93994169.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 3.43
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1091920000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 218610000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 218610000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 96238806.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 3.35
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 322400000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — EBIT: 423200000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — EBITDA: 641810000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 1505370000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 59600000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 59600000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Net Income: 322400000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 322400000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 322400000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 322400000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 322400000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 322400000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -59600000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -59600000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 641810000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 322400000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Operating Income: 390040000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 2597290000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 33160000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 465690000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 363600000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1091920000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 218610000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 41200000.00
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.11
NEPHROPLUS.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 2207250000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — +Operating Expense: 4365870000.00
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1275350000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — +Total Revenue: 9944680000.00
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 2656150000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 1430070000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1430070000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 3168910000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 3168910000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Accumulated Depreciation: -3110280000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -3110280000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Additional Paid In Capital: 10224520000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 10224520000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -479810000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -479810000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Amortization: 70640000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Amortization Cash Flow: 70640000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 352450000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 352450000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Basic Average Shares: 90590998.00
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 100231023.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Basic EPS: 8.48
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 3.03
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 1258170000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Buildings And Improvements: 1911280000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 1911280000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1193620000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 566880000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 566880000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 200680000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 200680000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 1238890000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1238890000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4567000000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4567000000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Cash Equivalents: 342250000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 342250000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Cash Financial: 896640000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Cash Financial: 896640000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -54930000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -137660000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 475310000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Change In Payable: 328070000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -687940000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -56410000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -207470000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Common Stock: 200680000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 200680000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 11164930000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 11164930000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 3902050000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 184650000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 184650000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 4189330000.00
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1101570000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Current Assets: 8391680000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 8391680000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 116120000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 116120000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Current Debt: 229720000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 229720000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 345840000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 345840000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 2994110000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 2994110000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 24370000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 24370000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Depreciation: 824210000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 894850000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 894850000.00
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 258450000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 824210000.00
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 258450000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Diluted Average Shares: 94833175.00
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 102601351.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Diluted EPS: 8.10
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.96
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 768400000.00
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 303700000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — EBIT: 1554400000.00
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — EBIT: 363990000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — EBITDA: 2449250000.00
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — EBITDA: 622440000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 188190000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — End Cash Position: 1238890000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 1571090000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 1132170000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -91350000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 12760000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 303600000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Goodwill: 866930000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 866930000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 1205590000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1205590000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Gross Accounts Receivable: 3648720000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 3648720000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 7256900000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 7256900000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Gross Profit: 5755350000.00
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1554580000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Impairment Of Capital Assets: 11820000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Interest Expense: 579660000.00
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 31800000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 579660000.00
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 31800000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Interest Income: 97070000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Interest Income Non Operating: 97070000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -184780000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 79910000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Inventory: 330370000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 330370000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 11395120000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 11395120000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -4104350000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 352450000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 352450000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 3902050000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 450760000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 450760000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 470000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 470000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 451230000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 451230000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -1149070000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 58570000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 58570000.00
NEPHROPLUS.NS balance_sheet (annual, 2026-03-31) — Machinery Furniture Equipment: 5160970000.00
NEPHROPLUS.NS balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 5160970000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -545790000.00
NEPHROPLUS.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 3902050000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Net Income: 768400000.00
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — Net Income: 303700000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 768400000.00
NEPHROPLUS.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 303700000.00
NEPHROPLUS.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 768400000.00